1 “... to detect underlying structural vascular abnormality in a non-invasive way and to predict the risk...”

2 “... to detect underlying structural vascular abnormality in a non-invasive way and to predict the risk...”

3 “... in the development of direct-acting antiviral agents (DAAs) that target several types of non-structural proteins used...”

4 “... in the development of direct-acting antiviral agents (DAAs) that target several types of non-structural proteins used...”

5 “... with the advent of the Coleman technique for structural fat grafting that was associated with improved graft...”

6 “... with the advent of the Coleman technique for structural fat grafting that was associated with improved graft...”

7 “... structural and parameter uncertainties that affect the overall precision of the cost-effectiveness estimates....”

8

9 “... or the floor of the mouth. They can also spread or originate from the bony structures of the mandibles. Oral...”

10 “... or the floor of the mouth. They can also spread or originate from the bony structures of the mandibles. Oral...”

11 “... (24-hour care in a structured setting, usually for patients who are severely depressed, traumatized...”

12 “... (24-hour care in a structured setting, usually for patients who are severely depressed, traumatized...”

13 “...: inpatient hospitalization (i.e., 24-hour care in a structured setting, usually for patients who are severely...”

14 “...: inpatient hospitalization (i.e., 24-hour care in a structured setting, usually for patients who are severely...”

15 “...) and associated structures, and affect 5% to 12% of individuals. TMD can lead to chronic pain, tooth grinding...”

16 “...) and associated structures, and affect 5% to 12% of individuals. TMD can lead to chronic pain, tooth grinding...”

17 “... be structured for treating adults with eligible types of refractory or relapsed large B-cell lymphoma?...”

18 “... be structured for treating adults with eligible types of refractory or relapsed large B-cell lymphoma?...”

19 “... Canadian jurisdictions structure the provision of axicabtagene ciloleucel to adults with large B-cell...”

20 “... Canadian jurisdictions structure the provision of axicabtagene ciloleucel to adults with large B-cell...”